When diagnostic uncertainty arose, molecular testing was performed in six cases, for example, testing for MIB-1 to distinguish from Spitz naevus, HMB45 to differentiate from atypical Spitz tumour and S100 to identify spindle cell melanoma from atypical spindle cell tumour. This evidence concerns the gene MIB1 and spindle cell neoplasm.